Falanga A - Search Results

1

Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura.

Consonni R, Falanga A, Barbui T. Consonni R, et al. Among authors: falanga a. Br J Haematol. 1994 Jun;87(2):321-4. doi: 10.1111/j.1365-2141.1994.tb04916.x. Br J Haematol. 1994. PMID: 7947274

2

Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.

Finazzi G, Bellavita P, Falanga A, Viero P, Barbui T. Finazzi G, et al. Among authors: falanga a. Am J Hematol. 1992 Nov;41(3):165-9. doi: 10.1002/ajh.2830410305. Am J Hematol. 1992. PMID: 1415190

3

A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura.

Falanga A, Consonni R, Ruggenenti P, Barbui T. Falanga A, et al. Br J Haematol. 1991 Nov;79(3):474-80. doi: 10.1111/j.1365-2141.1991.tb08058.x. Br J Haematol. 1991. PMID: 1751375

4

Cancer procoagulant in acute lymphoblastic leukemia.

Alessio MG, Falanga A, Consonni R, Bassan R, Minetti B, Donati MB, Barbui T. Alessio MG, et al. Among authors: falanga a. Eur J Haematol. 1990 Aug;45(2):78-81. doi: 10.1111/j.1600-0609.1990.tb00421.x. Eur J Haematol. 1990. PMID: 2209822

5

Inhibition of cancer procoagulant by peptidyl diazomethyl ketones and peptidyl sulfonium salts.

Falanga A, Shaw E, Donati MB, Consonni R, Barbui T, Gordon S. Falanga A, et al. Thromb Res. 1989 Jun 1;54(5):389-98. doi: 10.1016/0049-3848(89)90209-0. Thromb Res. 1989. PMID: 2772865

6

Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid.

Falanga A, Iacoviello L, Evangelista V, Belotti D, Consonni R, D'Orazio A, Robba L, Donati MB, Barbui T. Falanga A, et al. Blood. 1995 Aug 1;86(3):1072-81. Blood. 1995. PMID: 7620161 Free article.

7

Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery.

Falanga A, Ofosu FA, Cortelazzo S, Delaini F, Consonni R, Caccia R, Longatti S, Maran D, Rodeghiero F, Pogliani E, et al. Falanga A, et al. Br J Haematol. 1993 Dec;85(4):745-50. doi: 10.1111/j.1365-2141.1993.tb03218.x. Br J Haematol. 1993. PMID: 7918039

8

Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid.

Falanga A, Consonni R, Marchetti M, Mielicki WP, Rambaldi A, Lanotte M, Gordon SG, Barbui T. Falanga A, et al. Leukemia. 1994 Jan;8(1):156-9. Leukemia. 1994. PMID: 8289480

9

All-trans-retinoic acid counteracts endothelial cell procoagulant activity induced by a human promyelocytic leukemia-derived cell line (NB4).

Falanga A, Marchetti M, Giovanelli S, Barbui T. Falanga A, et al. Blood. 1996 Jan 15;87(2):613-7. Blood. 1996. PMID: 8555483 Free article.

10

Proteolysis of von Willebrand factor is decreased in acute promyelocytic leukaemia by treatment with all-trans-retinoic acid.

Federici AB, Falanga A, Lattuada A, Di Rocco N, Barbui T, Mannucci PM. Federici AB, et al. Among authors: falanga a. Br J Haematol. 1996 Mar;92(3):733-9. doi: 10.1046/j.1365-2141.1996.401939.x. Br J Haematol. 1996. PMID: 8616045

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters